ClinicalTrials.Veeva

Menu

Comparison of Three Modes of Ventilation During Robot-assisted Hysterectomy in Trendelenburg Position

H

Hallym University

Status

Unknown

Conditions

Anesthesia

Treatments

Device: Group VCV
Device: Group PCV
Device: Group PCV-VG

Study type

Interventional

Funder types

Other

Identifiers

NCT03887949
2017-I013

Details and patient eligibility

About

Robot-assisted hysterectomy is associated with pneumoperioneum with CO2 and Trendelenburg position, which may have adverse cardiopulmonary effects. A new ventilation mode; pressure-controlled ventilation with volume guaranteed mode (PCV-VG) delivers constant tidal volume with constant inspiratory pressure, using a decelerating flow pattern. This prospective, randomized study is designed to compare the effects of PCV-VG, volume-controlled ventilation (VCV) and pressure-controlled ventilation (PCV) on respiratory and hemodynamic variables in patients undergoing Robot-assisted hysterectomy.

Full description

  1. Total 60 patients with American Society of Anesthesiologists physical status I-II who underwent Robot-assisted hysterectomy were enrolled.
  2. All patients were fasted for 8 hours before the surgery and were premedicated with intramuscular glycopyrrolate 0.2 mg. Anesthesia was induced with intravenous remifentanil (0.1-0.2 ug/kg/min), propofol (1.5-2 mg/kg) and rocuronium (0.6 mg/kg) and maintained with sevoflurane (2.0-2.5 vol%) in inspired oxygen fraction with 0.5, remifentanil (0.05-0.3 ug/kg/min) and vecuronium (0.03-0.05 mg/kg/hr).
  3. A 20 G catheter was inserted into the radial artery to monitor continuous arterial pressure and hemodynamic variables (cardiac output, cardiac index, stroke volume, stroke volume index, and stroke volume variation) monitoring.
  4. All patients were ventilated with a Datex-Ohmeda Ventilator (S/5 AVANCE). Patients were randomized to receive VCV (n=20), PCV (n=20), or PCV-VG (n=20) mode. The tidal volume was set to deliver 8 mL/kg of ideal body weight. The respiratory rate(RR) was adjust to maintain end tidal CO2 (ETCO2) 32-37 mmHg.
  5. Hemodynamic variables (mean blood pressure, heart rate, cardiac output, cardiac index, stroke volume, stroke volume index, and stroke volume variation) , respiratory variables (saturation, RR, ETCO2, peak airway pressure, mean airway pressure and lung dynamic compliance) and arterial gas analyses were recorded at 4 stages: (1) 15 minutes after induction in supine position, (2) 30 minutes after pneumoperitoneum and Trendelenburg position, (3) 60 minutes after pneumoperitoneum and Trendelenburg position, (4) 15 minutes after pneumoperitoneum withdrawal in supine position.

Enrollment

60 estimated patients

Sex

Female

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who were scheduled for Robot-assisted hysterectomy
  • American Society of Anesthesiologists physical status I-II

Exclusion criteria

  • Age under 20 years old or over 65 years old
  • Body mass index > 30 kg/m2
  • Systolic blood pressure < 100 mmHg
  • Heart rate < 60 bpm
  • Uncompensated cardiac disease
  • FEV1 < 60%
  • Hypoxemia (PaO2 < 60 mmHg or oxygen saturation < 90%)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 3 patient groups

VCV
Active Comparator group
Description:
Volume controlled ventilation
Treatment:
Device: Group VCV
PCV
Active Comparator group
Description:
Pressure controlled ventilation
Treatment:
Device: Group PCV
PCV-VG
Experimental group
Description:
Pressure controlled ventilation with volume guarantee
Treatment:
Device: Group PCV-VG

Trial contacts and locations

1

Loading...

Central trial contact

Eun Young Park, MD; Jung Min Lee, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems